Skin cancer bill to skyrocket by 2015, Australian study finds

November 19, 2012 by Sunanda Creagh
Skin cancer bill to skyrocket by 2015
Over 55s made up the bulk of people seeking treatment for skin cancer in 2010, the study said. Credit: http://www.flickr.com/photos/redkoala1

Taxpayers will be spending over $700m annually to treat Australia's most common skin cancers by the year 2015, with over-65s making up the bulk of patients, a new study has found.

Non- skin cancers, which include (BCC) and (SCC), are less deadly but more common than melanoma skin cancers and make up the majority of cancer cases in Australia.

So vast is the number of people needing non-melanoma skin cancers cut out, cancer registries would be overloaded if they collected data on them, said the study's lead author, St Vincent's Hospital Melbourne dermatologist Professor Rodney Sinclair.

Instead, the authors of the study researched data from the Medicare Benefits Schedule to assess the current and future scale of the problem. Their results are published in the today.

The team found that treatment for non-melanoma skin cancers soared 86% between 1997 and 2010 and is on track to rise by a further 22% between 2010 and 2015. Skin cancers are more likely to appear in older people and the will place extra pressure on medical infrastructure in coming years, the study found.

The cost jumped from $264 million in 2001 to $511 million in 2010, is projected to cost $703 million to the public by 2015.

"That's the cost to government. The cost to patients, the out of pocket expense, will be at least 30% or 40% more from that," said Prof Sinclair, adding that the figures didn't include loss in productivity caused by time off work.

"It's totally reinforced our clinical impression, which was that we are seeing a lot more skin cancer out in the community," said Prof Sinclair, adding that some sufferers of non-melanoma skin cancers need 30 cut out every year.

Prof Sinclair said projecting the future cost of the problem allowed authorities to plan enough medical infrastructure to deal with the problem.

In 2010, 83% of the 767,347 non-melanoma skin cancer treatments needed were for over-55s, while in 2015 it's expected that more than 630,000 of the 900,000 treatments needed will be for over-65s.

Bruce Armstrong, professor of public health at the University of Sydney, said it was an important study that underscored the gravity of the skin cancer problem in Australia.

"This is real. It's an extremely important cancer and we are still not doing anywhere near enough to deal with it," he said, calling for increased spending on public shade cloths on streets and near sports grounds.

"This research shows that investment can be repaid rather quickly by savings on the cost of treatments," said Prof Armstrong, who was not involved in the study.

He said the latest NSW Skin Cancer Prevention Strategy, released last week, outlined some good measures for reducing the incidence of .

People should apply sunscreen often and ensure that using it doesn't embolden them to stay out in the sun longer than they otherwise would, he said.

Ian Olver, Clinical Professor of Oncology at Cancer Council Australia said the scale of the problem would keep increasing.

"It may be that what we are seeing is the result of exposure to the sun decades ago," he said.

Explore further: Increased tanning bed use increases risk for deadly skin cancers

Related Stories

Increased tanning bed use increases risk for deadly skin cancers

October 24, 2011
Researchers confirmed an association between tanning bed use and an increased risk for three common skin cancers — basal cell carcinoma, squamous cell carcinoma and melanoma, according to results presented at the 10th ...

Suggested link between radon and skin cancer

November 14, 2011
A new study published this week suggests that a link may exist between radon exposure and non-melanoma skin cancer.

Recommended for you

Shooting the achilles heel of nervous system cancers

July 20, 2017
Virtually all cancer treatments used today also damage normal cells, causing the toxic side effects associated with cancer treatment. A cooperative research team led by researchers at Dartmouth's Norris Cotton Cancer Center ...

Molecular changes with age in normal breast tissue are linked to cancer-related changes

July 20, 2017
Several known factors are associated with a higher risk of breast cancer including increasing age, being overweight after menopause, alcohol intake, and family history. However, the underlying biologic mechanisms through ...

Immune-cell numbers predict response to combination immunotherapy in melanoma

July 20, 2017
Whether a melanoma patient will better respond to a single immunotherapy drug or two in combination depends on the abundance of certain white blood cells within their tumors, according to a new study conducted by UC San Francisco ...

Discovery could lead to better results for patients undergoing radiation

July 19, 2017
More than half of cancer patients undergo radiotherapy, in which high doses of radiation are aimed at diseased tissue to kill cancer cells. But due to a phenomenon known as radiation-induced bystander effect (RIBE), in which ...

Definitive genomic study reveals alterations driving most medulloblastoma brain tumors

July 19, 2017
The most comprehensive analysis yet of medulloblastoma has identified genomic changes responsible for more than 75 percent of the brain tumors, including two new suspected cancer genes that were found exclusively in the least ...

Novel CRISPR-Cas9 screening enables discovery of new targets to aid cancer immunotherapy

July 19, 2017
A novel screening method developed by a team at Dana-Farber/Boston Children's Cancer and Blood Disorders Center—using CRISPR-Cas9 genome editing technology to test the function of thousands of tumor genes in mice—has ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.